Compare Twist Bioscience Corp (TWST) vs Utilities Select Sector SPDR Fund (XLU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Twist Bioscience Corp vs Utilities Select Sector SPDR Fund — how do they compare? Twist Bioscience Corp trades at $125.52 (market cap $8.26B), while Utilities Select Sector SPDR Fund trades at $43.21. The key difference: Twist Bioscience Corp is trading nearer its 52-week high, Utilities Select Sector SPDR Fund nearer its low. Which is the better fit depends on your goals.
| TWST | XLU | |
|---|---|---|
Market Cap | $8.26B | — |
Sector | Health | — |
52-Week High | $153.10 | $47.73 |
52-Week Low | $24.16 | $41.86 |
Enterprise Value | $8.18B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Twist Bioscience (TWST) trades at $128.06, up 2.68% with a bearish technical signal despite recent AI-driven momentum. The company shows strong revenue growth (2025: $377M, 2026: $432M projected) but continues to report significant losses with negative net margins. Recent news highlights AI partnerships and a $300M stock offering, while analyst consensus remains predominantly bullish with 78.6% buy ratings.
TWST presents a high-risk growth opportunity with accelerating revenue but persistent profitability challenges. The stock's valuation appears stretched at P/S of 18.09, requiring successful execution on AI initiatives and path to EBITDA breakeven. Key risks include cash burn, competitive pressures, and dependence on emerging AI-driven drug discovery markets.
XLU trades at $43.45, up 0.86% with a bullish technical signal despite bearish moving averages. The utilities ETF shows neutral oscillators with RSI at 57.53, trading near key support at $43. Recent news highlights XLU's defensive positioning amid market volatility and AI power demand growth, though some analysts question its AI exposure concentration.
Outlook remains cautiously optimistic as utilities benefit from AI-driven power demand and defensive characteristics during economic uncertainty. Key risks include regulatory changes affecting data-center growth and interest rate sensitivity. The sector's stable dividend profile provides income support while growth potential depends on AI infrastructure expansion.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →About Utilities Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: electric utilities; water utilities; multi-utilities; independent power and renewable electricity producers; and gas utilities. The fund is non-diversified.
Read more on XLU →
